Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6863d70eaf0c9d1aa0c2d3e5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "FLUTICATONE VILO 200",
"description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.",
"price": 740.0,
"discountamount": 222.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"12 years",
"24 hours",
"increased risk",
"drugs interact",
"antiviral medications",
"recommended dose",
"airways open",
"reduce inflammation",
"acute asthma",
"asthma attacks",
"severe asthma",
"copd attacks",
"inhaler consistently",
"optimal results",
"breathing comfort",
"longacting bronchodilation",
"antiinflammatory power",
"inhaled corticosteroids",
"vilanterol antifungal",
"tricyclic antidepressants",
"taking betablockers",
"prescribed inform",
"tuberculosis rinse",
"headache hoarseness",
"initial phase",
"generally welltolerated",
"fluticatone vilo 200",
"exercise capacity",
"emphysema reduces",
"chronic bronchitis",
"relaxing muscles",
"rescue medicine",
"vilanterol relaxes",
"prevent symptoms",
"specially formulated",
"vilanterol 25 mcg",
"vilanterol powder",
"rare effects",
"ketoconazole ritonavir",
"healthcare provider",
"therapy common",
"potent corticosteroid",
"fluticasone furoate",
"side effects",
"lung function",
"vilanterol fluticasone furoate",
"copd exacerbations improves",
"inhalation fluticasone furoate",
"lung function quality",
"fixeddose inhalation powder",
"increase corticosteroid levels",
"fastacting inhaler inform",
"combination inhalation therapy",
"side effects consult",
"frequent side effects",
"inhalation longterm treatment",
"healthcare providers guidance",
"ritonavir itraconazole leading",
"highly effective corticosteroid",
"effective oncedaily treatment",
"heart rhythm disturbances",
"strong cyp3a4 inhibitors",
"hypokalemia mao inhibitors",
"atenolol propranolol diuretics",
"breastfeeding drug interactions",
"pregnant planning pregnancy",
"avoid oral thrush",
"sore throat cough",
"adolescents maintenance treatment",
"longterm maintenance treatment",
"prescription combination medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2140,
"imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png",
"tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:39:42.59Z",
"updatedon": "2025-07-04T07:41:47.804Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-200/2140",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "fluticasone furoate and vilanterol powder for inhalation",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6863d2854c1970de3d96ebcd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "FLUTICATONE VILO 100",
"description": "FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness.\n\nThis powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term control of asthma symptoms such as wheezing, coughing, and breathlessness\n\nMaintenance treatment of COPD, including chronic bronchitis and emphysema\n\nPrevention of asthma exacerbations and hospitalizations\n\nImprovement in lung function and quality of life in chronic respiratory patients\n\nRegular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations.\n\nFluticasone Furoate and Vilanterol Powder for Inhalation Side Effects\nWhile generally well-tolerated, some users may experience mild to moderate side effects including:\n\nHeadache\n\nThroat irritation\n\nHoarseness of voice\n\nOral thrush (fungal infection in the mouth)\n\nCough or upper respiratory tract infections\n\nIncreased heart rate or palpitations\n\nMuscle cramps or tremors\n\nRare allergic reactions like rash, itching, or swelling\n\nTo minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation.\n\nPrecautions Before Using FLUTICATONE VILO 100\nDo not use it to treat sudden asthma attacks; it is not a rescue inhaler.\n\nInform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems.\n\nUse with caution in pregnancy and breastfeeding; consult your physician.\n\nRegular monitoring of lung function and adrenal activity is recommended during long-term use.\n\nChildren and adolescents may require special dose adjustments under medical supervision.\n\nDrug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol?\nSeveral medications may interact with this combination and alter its effectiveness or increase the risk of side effects:\n\nBeta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol\n\nKetoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects\n\nDiuretics: May increase the risk of hypokalemia when used with vilanterol\n\nOther corticosteroids: Concurrent use may enhance systemic corticosteroid side effects\n\nMAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects\n\nAlways inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100.\n\nConclusion\nFLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.",
"price": 525.0,
"discountamount": 158.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"combination ensures",
"improved quality",
"medications supplements",
"drugs interact",
"mouth cough",
"reduce dependency",
"synthetic corticosteroid",
"asthma attacks",
"asthma exacerbations",
"asthma symptoms",
"persistent asthma",
"vilanterol powder",
"controls inflammation",
"reduces inflammation",
"vilanterol ketoconazole",
"lungs vilanterol",
"vilanterol 25 mcg",
"essential component",
"bronchodilating effect",
"antiinflammatory strength",
"herbal products",
"healthcare provider",
"tricyclic antidepressants",
"corticosteroids concurrent",
"blood raising",
"bronchodilatory effect",
"adrenal activity",
"breastfeeding consult",
"liver problems",
"fluticatone vilo 100",
"oral thrush",
"rash itching",
"experience mild",
"generally welltolerated",
"emphysema prevention",
"wheezing coughing",
"prescription medication",
"airflow obstruction",
"constriction making",
"chest tightness",
"wheezing shortness",
"inhalation precautions",
"rescue inhalers",
"hospitalizations improvement",
"prevent flareups",
"improves breathing",
"fluticasone furoate",
"chronic bronchitis",
"lung function",
"relaxing muscles",
"rescue inhaler inform",
"adolescents fluticasone furoate",
"manage chronic symptoms",
"inhalation fluticasone furoate",
"lung function improvement",
"effective longterm control",
"breathing fewer flareups",
"inhalation longterm control",
"relaxing airway muscles",
"inhalation side effects",
"longterm maintenance treatment",
"provide longterm relief",
"chronic respiratory care",
"consistent symptom control",
"amplify cardiovascular effects",
"side effects diuretics",
"strong cyp3a4 inhibitors",
"side effects betablockers",
"physician regular monitoring",
"palpitations muscle cramps",
"moderate side effects",
"breathlessness maintenance treatment",
"acute bronchospasm relief",
"fastacting treatment choice"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2139,
"imageuri": "https://productimages.withfloats.com/actual/6863d28eeb66715cb5e18de8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6863d28eeb66715cb5e18de8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:20:21.253Z",
"updatedon": "2025-07-01T12:28:46.31Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-100/2139",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "fluticasone furoate and vilanterol powder for inhalation",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6819e619af35b11ab7f87163",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "BUDEPRESS FORTE 400 CAPSULES",
"description": "BUDEPRESS FORTE 400 combines powerful inhalation therapy ingredients to manage asthma and chronic obstructive pulmonary disease (COPD). This medication contains Formoterol Fumarate (12 mcg) and Budesonide IP (400 mcg), working together to alleviate and prevent respiratory symptoms including wheezing, shortness of breath, chest constriction, and chronic coughing. It delivers both sustained control and quick symptom relief, enhancing lung function and life quality.\nActive Components:\nFormoterol Fumarate (12 mcg)\nA long-acting beta-2 adrenergic agonist (LABA) that delivers quick and extended bronchodilation by relaxing airway muscles. Effects begin within minutes and continue for up to 12 hours, making it excellent for ongoing therapy.\nBudesonide IP (400 mcg)\nA strong inhaled corticosteroid (ICS) that reduces lung inflammation, swelling, and mucus production—primary factors contributing to asthma and COPD symptoms.\nPrimary Advantages:\nCombination therapy featuring both bronchodilator and anti-inflammatory for comprehensive respiratory management.\nQuick relief from bronchial constriction and breathing difficulties.\nExtended symptom control lasting up to 12 hours with regular administration.\nReduces asthma attack frequency and COPD flare-up severity.\nEnhances respiratory function for easier, more comfortable breathing.\nRequires fewer daily doses compared to short-acting alternatives.\nAppropriate for moderate to severe respiratory conditions under medical guidance.\nMechanism of Action:\nBUDEPRESS FORTE 400 operates through complementary actions of its two key ingredients:\nFormoterol Fumarate eases bronchial tube smooth muscles, creating airway expansion and rapid relief from narrowing that causes breathing distress.\nBudesonide, as an anti-inflammatory steroid, addresses underlying airway inflammation causing chronic symptoms and exacerbations. It diminishes hyperresponsiveness and mucus accumulation with consistent use.\nTogether, they prevent airway tightening, decrease inflammation, and facilitate smooth airflow, offering better management of chronic respiratory conditions.\nUsage Instructions:\nUse only as prescribed by your healthcare provider.\nTypically administered twice daily (morning and evening), though dosage may vary based on condition severity and individual response.\nShake inhaler thoroughly before each use.\nRinse mouth completely with water after each use to avoid oral thrush (fungal infection).\nNever exceed the prescribed dosage.\nFor effective management, maintain consistent use even when symptoms improve.\nPotential Side Effects:\nMost patients tolerate BUDEPRESS FORTE 400 well, though side effects may occur:\nCommon Effects:\n\nVoice changes or hoarseness\nDry mouth or throat irritation\nCoughing or throat discomfort\nHeadache\nMild trembling or shakiness\nElevated heart rate (palpitations)\n\nLess Common but Serious Effects:\n\nOral or throat fungal infection (thrush)\nAllergic responses (rash, swelling, breathing difficulty)\nMuscle cramping\nChest discomfort\nWorsening respiratory issues (paradoxical bronchospasm)\n\nContact your physician immediately for persistent or severe side effects.\nImportant Precautions:\nNot for acute asthma attack treatment—always maintain a rescue inhaler for emergencies.\nInform your doctor about heart conditions, diabetes, thyroid disorders, or liver issues.\nAvoid exposure to contagious diseases (e.g., chickenpox, measles) while using corticosteroid therapy.\nPregnant or nursing women should consult healthcare providers before using.\nStore securely away from children.\nBUDEPRESS FORTE 400 provides a clinically validated, dual-action approach to respiratory comfort—combining immediate relief with long-term management. With proper medical supervision, it significantly improves daily activity levels and decreases respiratory symptom burden.",
"price": 940.0,
"discountamount": 282.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"12 hours",
"prescribed dosage",
"longterm management",
"rapid relief",
"12 hours making",
"delivers quick",
"manage asthma",
"store securely",
"nursing women",
"chickenpox measles",
"contagious diseases",
"emergencies inform",
"rescue inhaler",
"physician immediately",
"effects oral",
"side effects",
"condition severity",
"vary based",
"daily morning",
"mucus accumulation",
"diminishes hyperresponsiveness",
"complementary actions",
"shortacting alternatives",
"extended bronchodilation",
"sustained control",
"wheezing shortness",
"bronchial constriction",
"chronic coughing",
"respiratory comfortcombining",
"throat irritation coughing",
"breath chest constriction",
"severe respiratory conditions",
"prevent respiratory symptoms",
"proper medical supervision",
"consult healthcare providers",
"corticosteroid therapy pregnant",
"hoarseness dry mouth",
"rinse mouth completely",
"breathing distress budesonide",
"medical guidance mechanism"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2101,
"imageuri": "https://productimages.withfloats.com/actual/6819e61c974ab387c1d08df8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6819e61c974ab387c1d08df8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-06T10:36:09.795Z",
"updatedon": "2025-05-06T10:36:09.795Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/budepress-forte-400-capsules/2101",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Formoterol Fumarate (12 mcg), Budesonide IP (400 mcg)",
"category": "ASTHMARANGE",
"tags": [
"Formoterol fumarate and budesonide powder for inhalation ip",
"Formoterol fumarate and Budesonide powder for inhalation ip uses",
"Formoterol fumarate and budesonide inhaler dosage",
"Formoterol fumarate and Budesonide Powder for Inhalation IP 400"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66308ff91e5f32235c82e5a6",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "CONARIS SB 130 ",
"description": "CONARIS SB 130 \nItraconazole (130 mg)\nConaris SB 130 is a medication containing Itraconazole, with each tablet containing 130 mg of the active ingredient. Itraconazole belongs to the class of antifungal medications and is used to treat fungal infections in various parts of the body, including the lungs, mouth, throat, toenails, and fingernails.\n\nThis medication works by inhibiting the growth of fungi, thereby helping to eliminate the infection. It is commonly prescribed for conditions such as fungal pneumonia, oral thrush, ringworm, and fungal nail infections.\n\nIt is important to follow your doctor's instructions and the dosage prescribed. Common side effects may include nausea, vomiting, diarrhea, headache, or dizziness. If you experience severe side effects or allergic reactions, seek medical attention immediately.\n\nConaris SB 130 should be stored at room temperature away from moisture and heat. Keep it out of reach of children and pets. Do not share this medication with others without medical advice.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n",
"price": 255.0,
"discountamount": 77.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"mg",
"heat",
"pets",
"body",
"mouth",
"reach",
"fungi",
"lungs",
"class",
"nausea",
"dosage",
"doctor",
"growth",
"throat",
"tablet",
"others",
"children",
"moisture",
"toenails",
"headache",
"diarrhea",
"ringworm",
"vomiting",
"dizziness",
"CONARIS SB",
"conditions",
"oral thrush",
"fingernails",
"Itraconazole",
"instructions",
"various parts",
"medical advice",
"fungal pneumonia",
"room temperature",
"active ingredient",
"medical attention",
"fungal infections",
"allergic reactions",
"severe side effects",
"Common side effects",
"antifungal medications",
"fungal nail infections"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 853,
"imageuri": "https://productimages.withfloats.com/actual/66308ffdfa384161ec2bd82d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66308ffdfa384161ec2bd82d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-04-30T06:30:17.566Z",
"updatedon": "2024-06-12T12:39:58.669Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/conaris-sb-130-/853",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Itraconazole (130 mg)",
"category": "DERMATALOGY",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "662b754818870a17183d43ec",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "CANDISTRUM 16 ",
"description": "CANDISTRUM 16 \nCandesartan (16mg)\nCANDISTRUM 16 is an antifungal medication primarily used to treat candidiasis and other fungal infections. It works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes, effectively stopping the growth and spread of fungal cells. CANDISTRUM 16 is ideal for patients seeking a reliable treatment for infections like thrush, yeast infections, and systemic candidiasis. With its targeted action, it ensures rapid relief from symptoms and helps prevent recurrence. Suitable for adults and supervised treatment in children, it's commonly administered in situations where first-line therapies have not been successful.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n",
"price": 188.0,
"discountamount": 57.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"adults",
"thrush",
"spread",
"growth",
"symptoms",
"patients",
"children",
"synthesis",
"CANDISTRUM",
"recurrence",
"ergosterol",
"situations",
"Candesartan",
"rapid relief",
"fungal cells",
"targeted action",
"yeast infections",
"reliable treatment",
"critical component",
"first-line therapies",
"systemic candidiasis",
"antifungal medication",
"fungal cell membranes",
"other fungal infections"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 747,
"imageuri": "https://productimages.withfloats.com/actual/662b754bcf52ae8ffbe3a416.png",
"tileimageuri": "https://productimages.withfloats.com/tile/662b754bcf52ae8ffbe3a416.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-04-26T09:35:04.74Z",
"updatedon": "2024-06-07T12:27:39.634Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/candistrum-16-/747",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Candesartan (16mg)",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68d51d9a26579f4bc195771a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ",
"description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ",
"price": 263.0,
"discountamount": 80.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2182,
"imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-25T10:46:50.098Z",
"updatedon": "2025-09-25T10:46:50.098Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS MV1 0.2",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68d518ce6b4e65282a1dc798",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg",
"description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)",
"price": 238.0,
"discountamount": 72.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2181,
"imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-25T10:26:22.554Z",
"updatedon": "2025-09-25T10:26:22.554Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BUDESHINE F 400 CAP",
"category": "ASTHMA RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68d2786bf4017fefeee0b981",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ketorolac tromethamine dispersible tablets 10 mg",
"description": "KEYPROFEN DT is a fast-acting nonsteroidal anti-inflammatory drug (NSAID) used to relieve moderate pain and inflammation. Its dispersible tablet form ensures quick dissolution and faster pain relief, making it convenient for oral administration. Ideal for managing post-operative pain, musculoskeletal discomfort, and other short-term pain conditions.",
"price": 166.0,
"discountamount": 49.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2180,
"imageuri": "https://productimages.withfloats.com/actual/68d2786fd0799a6bd13134e7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68d2786fd0799a6bd13134e7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-23T10:37:31.507Z",
"updatedon": "2025-09-23T10:37:31.507Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/ketorolac-tromethamine-dispersible-tablets-10-mg/2180",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "KEYPROFEN DT",
"category": "GENERAL RANGE",
"tags": [
"KEYPROFEN DT",
"ketorolac tromethamine dispersible tablets 10 mg uses in hindi",
"ketorolac tromethamine dispersible tablets 10 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68c29ba02244c906e7790e2b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TELAVINCE 300",
"description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.",
"price": 1480.0,
"discountamount": 444.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2179,
"imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-11T09:51:28.508Z",
"updatedon": "2025-09-11T09:51:28.508Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}